DDAH1 and gastric cancer: Otherwise, low expression of Dimethylarginine dimethylaminohydrolase 1 (DDAH1), which exhibited tumor suppression effects on gastric cancer, was also recognized as a potential predictor for more aggressive phenotypes and poor prognosis of gastric cancer [30].